Pro-Dex, Inc.

NasdaqCM PDEX

Pro-Dex, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2024: USD 6.41 M

Pro-Dex, Inc. Free Cash Flow is USD 6.41 M for the Trailing 12 Months (TTM) ending September 30, 2024, a 214.02% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Pro-Dex, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 2.04 M, a 224.01% change year over year.
Pro-Dex, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2022 was USD -1.65 M, a 78.26% change year over year.
Pro-Dex, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2021 was USD -7.57 M, a -315.47% change year over year.
Pro-Dex, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 3.51 M, a 34.42% change year over year.

Key data

Date	Free Cash Flow	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities

NasdaqCM: PDEX

Pro-Dex, Inc.

CEO	Mr. Richard Lee Van Kirk Jr.
IPO Date	Aug. 7, 1986
Location	United States
Headquarters	2361 McGaw Avenue
Employees	146
Sector	Health Care
Industries Medical Instruments

Description

Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.

Key trends

Past 5 years